These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 9926973)
1. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol. Krcmery V; Mateicka F; Kunová A; Spánik S; Gyarfás J; Sycová Z; Trupl J Support Care Cancer; 1999 Jan; 7(1):39-43. PubMed ID: 9926973 [TBL] [Abstract][Full Text] [Related]
2. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. Krcmery V; Oravcova E; Spanik S; Mrazova-Studena M; Trupl J; Kunova A; Stopkova-Grey K; Kukuckova E; Krupova I; Demitrovicova A; Kralovicova K J Antimicrob Chemother; 1998 Mar; 41(3):373-80. PubMed ID: 9578164 [TBL] [Abstract][Full Text] [Related]
3. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Benjamin DK; Ross K; McKinney RE; Benjamin DK; Auten R; Fisher RG Pediatrics; 2000 Oct; 106(4):712-8. PubMed ID: 11015513 [TBL] [Abstract][Full Text] [Related]
4. Trichosporon beigelii, a new neonatal pathogen. Yoss BS; Sautter RL; Brenker HJ Am J Perinatol; 1997 Feb; 14(2):113-7. PubMed ID: 9259910 [TBL] [Abstract][Full Text] [Related]
5. Candida krusei fungemia. An escalating serious infection in immunocompromised patients. Abbas J; Bodey GP; Hanna HA; Mardani M; Girgawy E; Abi-Said D; Whimbey E; Hachem R; Raad I Arch Intern Med; 2000 Sep; 160(17):2659-64. PubMed ID: 10999981 [TBL] [Abstract][Full Text] [Related]
6. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model. Tokimatsu I; Kushima H; Hashinaga K; Umeki K; Ohama M; Ishii H; Kishi K; Hiramatsu K; Kadota J Int J Antimicrob Agents; 2007 Jan; 29(1):84-8. PubMed ID: 17189098 [TBL] [Abstract][Full Text] [Related]
7. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma. Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484 [TBL] [Abstract][Full Text] [Related]
8. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp. Ramírez I; Moncada D Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871 [TBL] [Abstract][Full Text] [Related]
9. Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, etiology and outcome. Kralovicova K; Spanik S; Oravcova E; Mrazova M; Morova E; Gulikova V; Kukuckova E; Koren P; Pichna P; Nogova J; Kunova A; Trupl J; Krcmery V Scand J Infect Dis; 1997; 29(3):301-4. PubMed ID: 9255894 [TBL] [Abstract][Full Text] [Related]
10. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome. Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369 [TBL] [Abstract][Full Text] [Related]
11. Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review. Krcmery V; Spanik S; Kunova A; Trupl J; Grausova S; Krupova I; Mateicka F; Pichnova E; Grey E; Sabo A J Chemother; 1999 Apr; 11(2):131-6. PubMed ID: 10326744 [TBL] [Abstract][Full Text] [Related]
12. [Retrospective analysis of 15 patients with fungal septicaemia]. Deng G; Wang A Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):594-6. PubMed ID: 11758238 [TBL] [Abstract][Full Text] [Related]
13. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648 [TBL] [Abstract][Full Text] [Related]
15. Persistent fungemia--risk factors and outcome in 40 episodes. Kovacicova G; Lovaszova M; Hanzen J; Roidova A; Mateicka F; Lesay M; Krcméry V J Chemother; 2001 Aug; 13(4):429-33. PubMed ID: 11589487 [TBL] [Abstract][Full Text] [Related]
16. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial. Boogaerts M; Winston DJ; Bow EJ; Garber G; Reboli AC; Schwarer AP; Novitzky N; Boehme A; Chwetzoff E; De Beule K; Ann Intern Med; 2001 Sep; 135(6):412-22. PubMed ID: 11560454 [TBL] [Abstract][Full Text] [Related]
17. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B. Hosokawa K; Yamazaki H; Mochizuki K; Ohata K; Ishiyama K; Hayashi T; Kondo Y; Sugimori N; Okumura H; Takami A; Nakao S Transpl Infect Dis; 2012 Apr; 14(2):184-7. PubMed ID: 22093149 [TBL] [Abstract][Full Text] [Related]
19. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate. Goodman D; Pamer E; Jakubowski A; Morris C; Sepkowitz K Clin Infect Dis; 2002 Aug; 35(3):E35-6. PubMed ID: 12115115 [TBL] [Abstract][Full Text] [Related]
20. Disseminated Trichosporon asahii infection in a patient with acute myeloid leukemia. Cardenas-de la Garza JA; Ancer-Arellano J; Cuellar-Barboza A; Saenz-Ibarra B; Ocampo-Garza SS; Barboza-Quintana O; Gallardo-Rocha A; Vera-Cabrera L; Ocampo-Candiani J; Welsh O J Dermatol; 2019 Apr; 46(4):e128-e129. PubMed ID: 30295013 [No Abstract] [Full Text] [Related] [Next] [New Search]